Evaluating the Occurrence of DKA in People With Type I Diabetes
NCT: NCT07739342 · NOT_YET_RECRUITING
NCT IDNCT07739342
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2027-12
SponsorAbbott Diabetes Care (INDUSTRY)
First posted
Last updated
Brief Summary
This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.
Frequently Asked Questions
What is Evaluating the Occurrence of DKA in People With Type I Diabetes?
Evaluating the Occurrence of DKA in People With Type I Diabetes is a clinical trial registered under NCT07739342. Current status: NOT_YET_RECRUITING.
What is the status of NCT07739342?
The current status of NCT07739342 (Evaluating the Occurrence of DKA in People With Type I Diabetes) is: NOT_YET_RECRUITING.
When did Evaluating the Occurrence of DKA in People With Type I Diabetes start?
Evaluating the Occurrence of DKA in People With Type I Diabetes started on 2026-09.
Related Devices
K212132FreeStyle Libre 3 Continuous Glucose Monitoring SystemAbbott Diabetes Care, Inc.
K213996FreeStyle Libre 3 Continuous Glucose Monitoring SystemAbbott Diabetes Care, Inc.
K222447FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring SystemAbbott Diabetes Care, Inc.
K223435FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc.
K233537FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.